Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

On January 28, 2022, Douglas R. Carlson informed Ikena Oncology, Inc. (the "Company") of his intent to resign as Chief Operating Officer and Executive Vice President of Finance of the Company to pursue other professional opportunities with broader responsibility. Mr. Carlson's resignation will be effective on February 18, 2022. Francisco Oliveira, the Head of Finance and Administration since 2019, will serve as Principal Accounting Officer and report directly to the Company's Chief Executive Officer, Mark Manfredi, on an interim basis effective as of Mr. Carlson's departure, while a formal search process to appoint a new Chief Financial Officer is conducted.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses